Egypt vs Liberia: Population requiring preventive chemotherapy for schistosomiasis
Egypt
2.98 million
in 2023
Liberia
2.49 million
in 2024
Egypt rank
26th
Liberia rank
28th
Population requiring preventive chemotherapy for schistosomiasis over time
- Egypt
- Liberia
How they compare
Egypt currently reports 2.98 million against 2.49 million in Liberia, a difference of 488,880.
That makes Egypt's figure about 1.2 times Liberia's.
The two have swapped places 1 time across 14 shared years of data; in 2010 it was Liberia ahead.
Egypt ranks 26th and Liberia ranks 28th of 52 countries.
Egypt has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Egypt | Liberia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.76 million | 1.12 million | 640,594 | Egypt |
| 2020s | 2.94 million | 1.15 million | 1.79 million | Egypt |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Egypt or Liberia?
- Egypt, at 2.98 million against 2.49 million in Liberia as of 2023.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Egypt and Liberia?
- 488,880, with Egypt ahead.
- How many years of comparable data are there for Egypt and Liberia?
- 14 years are reported by both, from 2010 to 2023.
- How do Egypt and Liberia rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Egypt ranks 26th and Liberia ranks 28th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.